Sun Pharmaceutical Industries
Recent Highlights
All Stories for Sun Pharmaceutical Industries
Sun Pharma Q3 net profit zooms nearly four-fold to Rs 1,242 crore; firm's shares rise 2% on BSE
•The company had posted a net profit of Rs 321.57 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a filing to BSE.
Sun Pharma arm gets relief from US court in patent infringement case
•Massachusetts-based DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AGf from using its confidential and proprietary trade secret information, Sun Pharmaceutical Industries said
Sebi examines whistleblower complaint against Sun Pharma: All you need to know about issue plaguing drugmaker
Fp Staff •In August 2017, Sun Pharmaceutical, Shanghvi and nine other entities settled an insider trading probe on payment of Rs 18 lakh towards settlement charges
Sun Pharma open to evaluate some past decisions; has not received any query so far from SEBI: Dilip Shanghvi
Fp Staff •Dilip Shanghvi, founder and managing director of Sun Pharma said the company will work towards re-establishing credibility and corporate governance
Sun Pharma shares gain 4% after USFDA clears drug major; market cap rises by Rs 2,384 cr
•Shares of Sun Pharmaceutical Industries on Wednesday gained nearly 4 percent after the company received establishment inspection report (EIR) from the US health regulator for its Halol facility in Gujarat
Sun Pharma receives EIR for its crucial Halol plant in Gujarat, US health regulator clears drug major
•Sun Pharmaceutical Industries said it has received establishment inspection report (EIR) from US health regulator for its Halol facility in Gujarat
Sun Pharma shares drop over 3% on disappointing earnings in Jul-Sep quarter
•Sun Pharma's consolidated total revenue from operations stood at Rs 6,650.34 crore
Sun Pharma forays into dermatology segment by launching sunscreen brand Suncros
•The world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product
Lumbering economy, El Nino fear make HSBC downgrade Indian equities to 'underweight'
Fp Archives •India remains one of the most over-owned market in Asia and the bank says the potential for more equity outflows has increased because foreign positions look stretched.
Sun Pharma gets RBI nod for transfer of Ranbaxy overseas investments
Fp Archives •The two firms have received nod from the Competition Commission for sale of seven brands to Emcure Pharma to comply with the fair trade watchdog's conditional nod for their merger.